Premium
Ethical issues in therapeutic use and research in pregnant and breastfeeding women
Author(s) -
Weld Ethel D.,
Bailey Theodore C.,
Waitt Catriona
Publication year - 2022
Publication title -
british journal of clinical pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.216
H-Index - 146
eISSN - 1365-2125
pISSN - 0306-5251
DOI - 10.1111/bcp.14914
Subject(s) - medicine , breastfeeding , pregnancy , alternative medicine , clinical trial , ethical issues , population , dosing , evidence based practice , family medicine , intensive care medicine , engineering ethics , pharmacology , pediatrics , environmental health , genetics , pathology , engineering , biology
Pregnant or potentially pregnant women have historically been excluded from clinical trials of new medications. However, it is increasingly recognised that it is imperative to generate evidence from the population in whom the drugs are likely to be used to inform safe, evidence‐based shared clinical decision making. Reluctance by researchers and regulators to perform such studies often relates to concerns about risk, particularly to the foetus. However, this must be offset against the risk of untreated disease or using a drug in pregnancy where safety, efficacy and dosing information are not known. This review summarises the historical perspective, and the ethical and legal frameworks that inform the conduct of such research, then highlights examples of innovative practice that have enabled high quality, ethical research to proceed to inform the evidence‐based use of medication in pregnancy.